Croda International (6CMB) Stock Price & Analysis
6CMB Stock Chart & Stats
- Day’s Range
- EUR 43.02 - EUR 43.02
- 52-Week Range
- EUR 28.65 - EUR 44.00
- Previous Close
- EUR 43.56
- Volume
- N/A
- Average Volume (3M)
- 11
- Market Cap
- EUR 6.05B
- Enterprise Value
- EUR 4.82B
- Total Cash (Recent Filing)
- EUR 205.30M
- Total Debt (Recent Filing)
- EUR 783.20M
- Price to Earnings (P/E)
- 64.5
- Beta
- 0.83
- Next Earnings
- Feb 23, 2027 (Est.)
- EPS Estimate
- 0.93
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.99%
Bulls Say, Bears Say
Bulls Say
Differentiated Specialty Chemicals Model
Croda’s formulation-critical products and technical support can embed the company in customer recipes, making substitution less straightforward after qualification. This value-added model supports repeat B2B demand, premium positioning and potentially more durable margins than commodity chemical exposure.
Organic Growth And Margin Expansion
The combination of organic sales growth, profit growth ahead of sales and wider margins indicates improving operating momentum. Reiterated 2026 guidance and sequential H2 margin expectations suggest management sees these gains as part of a broader recovery rather than a single isolated quarter.
Manageable Leverage And Positive Cash Generation
Conservative leverage and positive free cash flow provide financial flexibility to fund innovation, capacity and transformation while absorbing operating volatility. This balance-sheet capacity reduces dependence on external financing and supports continued investment in Croda’s longer-term growth priorities.
Bears Say
Post-2022 Earnings Normalization
The earnings reset after 2022 shows that Croda’s profitability has not yet returned to its prior peak and that reported growth remains uneven. A modest 2025 revenue rebound leaves the business exposed to a prolonged recovery period if demand and mix do not improve consistently.
Working-Capital Cash Conversion Pressure
The sizeable working-capital outflow means accounting profit and EBITDA are not converting efficiently into near-term cash. Although management targets structural savings, the delayed timing leaves liquidity and free-cash-flow improvement dependent on successful execution over multiple reporting periods.
Segment And Input-Cost Headwinds
Weakness in Crop Protection and lumpy Pharma Solutions demand creates uneven performance across Croda’s portfolio. At the same time, input inflation requires selective pricing actions, which may pressure margins if customers resist increases or market conditions limit recovery.
Croda International News
6CMB FAQ
What was Croda International’s price range in the past 12 months?
What is Croda International’s market cap?
When is Croda International’s upcoming earnings report date?
How were Croda International’s earnings last quarter?
Is Croda International overvalued?
Does Croda International pay dividends?
What is Croda International’s EPS estimate?
How many shares outstanding does Croda International have?
What happened to Croda International’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Croda International?
What is the TipRanks Smart Score and how is it calculated?
Croda International Stock Smart Score
Company Description
Croda International
Croda International Plc, established in 1925 and headquartered in Goole, United Kingdom, is a global leader in the development, manufacture, and supply of high-performance specialty chemicals. The company serves a diverse international client base across Europe, the Middle East, Africa, North America, Asia, and Latin America. Its operations are organized into four primary business segments: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. Croda's extensive product portfolio addresses a wide array of industrial and consumer needs. For the Consumer Care market, it delivers crucial ingredients for personal care products, spanning skin, hair, sun, and baby care, along with solutions for color cosmetics, oral hygiene, self-tanning, deodorants, men's grooming, and depilatories, as well as household and institutional cleaning formulations. In Life Sciences, the company provides innovative solutions for agriculture, including crop protection additives, seed enhancements, animal health chemicals, and bio-stimulants, alongside dietary supplements and active pharmaceutical ingredients. The Performance Technologies and Industrial Chemicals segments encompass a vast range of specialized materials. This includes additives for lubricants, coatings, polymers, batteries, and catalysts; materials for electronics, construction, and thermal management; adhesives; and chemicals for vehicle cleaning, automotive textiles, and plastic/rubber products. Furthermore, Croda supplies chemicals for packaging, printing, paper, paints, and water treatment, along with oleochemicals, emulsifiers, fuel additives, and specialty polymer additives for furniture and wood. The company also innovates in bio-based phase change materials, offering solutions for temperature control in buildings, clothing, healthcare, electronics, food refrigeration, energy storage, packaging, and automotive applications. This broad offering underscores Croda's commitment to delivering specialized chemical solutions across numerous critical industries.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Stephen Edward Foots
- Employees
- 5,954
- Website
- www.croda.com
- Address
- Cowick Hall, Goole, YO, DN14 9AA, GB
Croda International (6CMB) Earnings & Revenues
6CMB Earnings Call
Earnings Call SentimentPositive
The call presented a broadly positive operational and financial picture: organic growth, margin expansion, improved EPS and cash flow, strong outperformance in Consumer Care (notably Beauty Actives) and progress on transformation and AI initiatives. Headwinds remain in certain areas — Pharma Solutions phasing and lumpiness, Crop Protection weakness, regional F&F disruption, working-capital outflow and input-cost volatility — but management reiterated FY guidance and a clear path to their 3-year targets, viewing many challenges as within management control.
View all DE:6CMB earnings summaries6CMB Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 6 | 4 |
| Technical Analysis | 4 | 6 | 0 |
| Moving Averages | 8 | 0 | 4 |
